GTAB B — Glycorex Transplantation AB (publ) Cashflow Statement
0.000.00%
Last trade - 00:00- SEK147.71m
- SEK147.94m
- SEK35.16m
Annual cashflow statement for Glycorex Transplantation AB (publ), fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | R2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -8.05 | -12.2 | -8.52 | -30.4 | -11 |
| Depreciation | |||||
| Non-Cash Items | -0.086 | 0.166 | 8.52 | 0.149 | 9.47 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | 1.57 | 2.88 | -0.622 | -0.585 | 1.63 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 1.26 | -0.695 | -0.622 | -9.46 | 0.101 |
| Capital Expenditures | -2.01 | -2.55 | -2.13 | -3.55 | — |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | — | — | 0.235 | 0 | — |
| Sale of Fixed Assets | |||||
| Cash from Investing Activities | -2.01 | -2.55 | -1.9 | -3.55 | — |
| Financing Cash Flow Items | 39.9 | 0 | — | — | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 34.5 | -3.79 | -6.02 | -6.63 | -7.1 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 33.7 | -7.17 | -8.55 | -19.7 | -7.12 |